Gene: STIM2
Official Full Name: stromal interaction molecule 2provided by HGNC
Gene Summary: This gene is a member of the stromal interaction molecule (STIM) family and likely arose, along with related family member STIM1, from a common ancestral gene. The encoded protein functions to regulate calcium concentrations in the cytosol and endoplasmic reticulum, and is involved in the activation of plasma membrane Orai Ca(2+) entry channels. This gene initiates translation from a non-AUG (UUG) start site. A signal peptide is cleaved from the resulting protein. Multiple transcript variants result from alternative splicing. [provided by RefSeq, Dec 2009]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO08113 | STIM2 Knockout cell line (HeLa) | Human | STIM2 | 1:3~1:6 | Negative | Online Inquiry |
KO08114 | STIM2 Knockout cell line (HCT 116) | Human | STIM2 | 1:2~1:4 | Negative | Online Inquiry |
KO08115 | STIM2 Knockout cell line (HEK293) | Human | STIM2 | 1:3~1:6 | Negative | Online Inquiry |
KO08116 | STIM2 Knockout cell line (A549) | Human | STIM2 | 1:3~1:4 | Negative | Online Inquiry |
STIM2 Gene Knockout Cell Lines are genetically modified cellular models in which the STIM2 gene—crucial for cellular calcium signaling—has been silenced or completely eliminated. The deletion of this gene allows for the in-depth study of calcium homeostasis and associated signaling pathways, contributing crucial insights into various physiological processes and disease mechanisms.
The primary function of STIM2 is to act as a sensor of intracellular calcium levels, facilitating the release of calcium from the endoplasmic reticulum in response to a drop in cytosolic calcium concentrations. By employing CRISPR/Cas9 gene-editing technology to generate these knockout cell lines, researchers can meticulously investigate the implications of STIM2 modulation on cellular calcium signaling, reactive oxygen species production, and downstream cellular responses. This mechanism is particularly significant for understanding the roles of STIM2 in neurodegenerative diseases, immune responses, and other pathophysiological conditions.
In both research and clinical settings, STIM2 knockout cell lines provide a valuable platform for the development of targeted therapies. The disruption of this gene can help elucidate the contribution of cellular calcium signaling dysregulation to various diseases, fostering the discovery of novel therapeutic interventions. Additionally, these cell lines are integral tools for drug screening and mechanism-of-action studies, allowing scientists to explore the effects of compounds that target calcium signaling pathways.
What sets our STIM2 Gene Knockout Cell Lines apart from existing products is the meticulous validation and characterization that underpins their production. Each cell line has been screened and confirmed for STIM2 knockout efficiency, ensuring reproducibility and reliability in experimental outcomes. Furthermore, our product distinguishes itself through exceptional customer support, providing comprehensive technical assistance and protocol recommendations tailored to researchers' specific needs.
Choosing our STIM2 Gene Knockout Cell Lines means investing in a scientifically robust product that enhances your research capabilities. Backed by years of expertise in genetic engineering and a commitment to advancing scientific discovery, our company delivers high-quality biological tools to propel your research forward.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.